Effect of adenovirus‑mediated uPA gene transduction on the fibrinolytic activity of human umbilical vein endothelial cells

Zhou,Weimin

doi:10.3892/mmr.2014.2518

Effect of adenovirus‑mediated uPA gene transduction on the fibrinolytic activity of human umbilical vein endothelial cells

Authors:
- Weimin Zhou
View Affiliations

Affiliations: Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: August 26, 2014 https://doi.org/10.3892/mmr.2014.2518
Pages: 2701-2705

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the effect of adenovirus‑mediated urokinase‑type plasminogen activator (uPA) transduction on uPA expression and fibrinolytic activity in human umbilical vein endothelial cells (HUVECs). Recombinant adenovirus vectors containing the human uPA gene were constructed and transduced into HUVECs. The expression and fibrinolytic activity of uPA was then assessed in HUVECs using western blot analysis, ELISA and colorimetric assay. The experiments were performed in three groups: The ad/uPa (n=3), ad/neg control (n=3) and blank control (n=3) groups. Western blot analysis revealed that uPA protein expression in the HUVECs in the ad/uPa group was significantly increased compared with those in the ad/neg control or blank groups (P<0.01). The uPA protein levels in the supernatant of the three groups were 379.40±2.46, 240.01±1.16 and 256.10±3.04 ng/l, respectively, showing that the uPA protein levels were significantly higher in the supernatant in the ad/uPa group compared with those in the ad/neg control or blank groups. uPA activity was determined using a colorimetric method and was found to be 40238.49±5755 IU/mg in the HUVECs in the ad/uPa group, which was significantly higher than that in the HUVECs in the ad/neg control (6180.03±942.38 IU/mg) or blank groups (3346.06±928.81 IU/mg) (both P<0.01). These findings suggested that transduction of the uPA gene increased uPA protein expression and fibrinolytic activity in HUVECs.

View Figures

View References

1	Goldhaber SZ: Pulmonary embolism. Lancet. 363:1295–1305. 2004. View Article : Google Scholar : PubMed/NCBI
2	Spencer FA, Emery C, Lessard D, et al: The Worcester Venous Thromboembolism Study: A population based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med. 21:722–727. 2006. View Article : Google Scholar
3	Chapman NH, Brighton T, Harris MF, Caplan GA, Braithwaite J and Chong BH: Venous thromboembolism - management in general practice. Aust Fam Physician. 38:36–40. 2009.PubMed/NCBI
4	Pengo V, Lensing AW, Prins MH, et al: Thromboembolic Pulmonary Hypertension Study Group: Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 350:2257–2264. 2004. View Article : Google Scholar
5	Vincenza Carriero M, Franco P, Vocca I, et al: Structure, function and antagonists of urokinase-type plasminogen activator. Front Biosci (Landmark Ed). 14:3782–3794. 2009.PubMed/NCBI
6	Radha KS, Madhyastha HK, Nakajima Y, Omura S and Maruyama M: Emodin upregulates urokinase plasminogen activator, plasminogen activator inhibitor-1 and promotes wound healing in human fibroblasts. Vascul Pharmacol. 48:184–190. 2008. View Article : Google Scholar
7	Nassar T, Yarovoi S, Fanne RA, et al: Urokinase plasminogen activator regulates pulmonary arterial contractility and vascular permeability in mice. Am J Respir Cell Mol Biol. 45:1015–1021. 2011. View Article : Google Scholar : PubMed/NCBI
8	Baldwin JF, Sood V, Elfline MA, et al: The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis. J Vasc Surg. 56:1089–1097. 2012. View Article : Google Scholar : PubMed/NCBI
9	Rao Gogineni V, Kumar Nalla A, Gupta R, et al: Radiation-inducible silencing of uPA and uPAR in vitro and in vivo in meningioma. Int J Oncol. 36:809–816. 2010.PubMed/NCBI
10	Ylä-Herttuala S: Cardiovascular gene therapy with vascular endothelial growth factors. Gene. 525:217–219. 2013.
11	Zhao B, Li X, Dai X and Gong N: Adenovirus-mediated anti-sense extracellular signal-regulated kinase 2 gene therapy inhibits activation of vascular smooth muscle cells and angiogenesis, and ameliorates transplant arteriosclerosis. Transplant Proc. 45:639–642. 2013. View Article : Google Scholar
12	Dragneva G, Korpisalo P and Ylä-Herttuala S: Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success. Dis Model Mech. 6:312–322. 2013. View Article : Google Scholar : PubMed/NCBI
13	Kral BG and Kraitchman DL: From mice to men: gene therapy’s future for treatment of myocardial infarction. Circ Cardiovasc Imaging. 6:360–362. 2013.
14	Botkjaer KA, Fogh S, Bekes EC, et al: Targeting the autolysis loop of urokinase-type plasminogen activator with conformation-specific monoclonal antibodies. Biochem J. 438:39–51. 2011. View Article : Google Scholar : PubMed/NCBI
15	Sood V, Luke CE, Deatrick KB, et al: Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism. Thromb Haemost. 104:1174–1183. 2010. View Article : Google Scholar : PubMed/NCBI
16	Humphries J, Gossage JA, Modarai B, et al: Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis. J Vasc Surg. 50:1127–1134. 2009. View Article : Google Scholar : PubMed/NCBI
17	Madhyastha R, Madhyastha H, Nakajima Y, Omura S and Maruyama M: Curcumin facilitates fibrinolysis and cellular migration during wound healing by modulating urokinase plasminogen activator expression. Pathophysiol Haemost Thromb. 37:59–66. 2010. View Article : Google Scholar
18	Shenkman B, Livnat T, Budnik I, Tamarin I, Einav Y and Martinowitz U: Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator. Blood Coagul Fibrinolysis. 23:729–733. 2012. View Article : Google Scholar : PubMed/NCBI
19	Lipskaia L, Hadri L, Lopez JJ, Hajjar RJ and Bobe R: Benefit of SERCA2a gene transfer to vascular endothelial and smooth muscle cells: a new aspect in therapy of cardiovascular diseases. Curr Vasc Pharmacol. 11:465–479. 2013. View Article : Google Scholar
20	Hennessy EJ and Moore KJ: Using microRNA as an alternative treatment for hyperlipidemia and cardiovascular disease: cardio-miRs in the pipeline. J Cardiovasc Pharmacol. 62:247–254. 2013. View Article : Google Scholar : PubMed/NCBI
21	Won YW, McGinn AN, Lee M, Nam K, Bull DA and Kim SW: Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia. Biomaterials. 34:6229–6238. 2013. View Article : Google Scholar : PubMed/NCBI
22	Yamaguchi Y, Yamada K, Suzuki T, et al: Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl, D-Arg8]-vasopressin (dDAVP). Am J Physiol Endocrinol Metab. 287:E970–E976. 2004.
23	De Meyer SF, Deckmyn H and Vanhoorelbeke K: von Willebrand factor to the rescue. Blood. 113:5049–5057. 2009.PubMed/NCBI
24	Chey S, Claus C and Liebert UG: Validation and application of normalization factors for gene expression studies in rubella virus-infected cell lines with quantitative real-time PCR. J Cell Biochem. 110:118–128. 2010.PubMed/NCBI
25	Gu Z, Pan J, Bankowski MJ and Hayden RT: Quantitative real-time polymerase chain reaction detection of BK virus using labeled primers. Arch Pathol Lab Med. 134:444–448. 2010.PubMed/NCBI
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
27	Oliveira MS, Skinner F, Arshadmansab MF, et al: Altered expression and function of small-conductance (SK) Ca(2+)-activated K⁺ channels in pilocarpine-treated epileptic rats. Brain Res. 1348:187–199. 2010. View Article : Google Scholar : PubMed/NCBI
28	Liang F, Arora N, Zhang KL, et al: A new, multiplex, quantitative real-time polymerase chain reaction system for nucleic Acid detection and quantification. Methods Mol Biol. 1039:51–68. 2013. View Article : Google Scholar : PubMed/NCBI
29	Wagner EM: Monitoring gene expression: quantitative real-time rt-PCR. Methods Mol Biol. 1027:19–45. 2013. View Article : Google Scholar : PubMed/NCBI
30	Gentilini F and Turba ME: Two novel real-time PCR methods for genotyping the von Willebrand disease type I mutation in Doberman Pinscher dogs. Vet J. 197:457–460. 2013. View Article : Google Scholar : PubMed/NCBI